Health Canada’s February 2025 guidance marks a significant step in clarifying how machine learning–based medical devices will be assessed in Canada. The document outlines expectations for transparent model reporting, dataset documentation, and the submission of structured “change control” plans that track how algorithms evolve after approval. For developers, that means AI-enabled devices classed from II to IV will face more consistent evidence and monitoring requirements—fact
